Yield10 Bioscience Names Dr. Jay J. Thelen, Ph.D. to Scientific Advisory Board
July 11 2018 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new
technologies to create step-changes in yield for major food and
feed crops to enhance global food security, today announced that it
has named Jay J. Thelen, Ph.D., Professor of Biochemistry at
University of Missouri (“MU”) to its Scientific Advisory Board
(“SAB”).
“We are pleased to welcome Dr. Thelen to our Scientific Advisory
Board,” said Oliver Peoples, Ph.D., President and Chief Executive
Officer of Yield10 Bioscience. “Dr. Thelen and his team at
University of Missouri have conducted innovative research focused
on developing advanced technologies for boosting oil content in
oilseed crops, including gene traits we call C3007 and C3010. We
look forward to his contributions as an advisor as we move forward
developing novel yield traits intended to boost oil content in both
specialty and commodity oilseed crops.”
Jay J. Thelen, Ph.D., is currently a Professor of Biochemistry
at the University of Missouri where he has been since 2002, as well
as a researcher at the Bond Life Sciences Center. His recent
research has led to two fundamental discoveries related to the
activity and regulation of the ACCase complex, a key enzyme
involved in oil production. Dr. Thelen received a B.S. in
biological sciences from the University of Nebraska and a Ph.D. in
biological sciences from the University of Missouri, Columbia. He
was a postdoctoral fellow at Michigan State University.
“Last year, Yield10 took an option to evaluate our research
involving advanced crop science technology to boost oil content in
oilseed crops based on a target called ‘BADC’, a novel, negative
regulator of ACCase, a key enzyme in oil biosynthesis,” said Dr.
Thelen. “Yield10’s approach to innovate and expand crop yield
is based on incorporating metabolic engineering and predictive
models to enable gene discoveries, approaches that directly
complement the work we are doing in my lab to identify new genetic
targets for increasing oil content. I look forward to working with
Yield10 as the company develops new ways to improve oil yield and
ultimately, the economics of healthy, edible oils.”
Recently, Yield10 signed an exclusive worldwide license with the
University of Missouri covering two novel gene technologies to
boost oil content in oilseed crops including Camelina, canola and
soybean. This agreement provides Yield10 with access to the novel
genome-editing targets and patent applications related to C3007 and
C3010.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is focused on developing new
technologies to achieve step-change improvements in crop yield to
enhance global food security. Yield10 has an extensive track record
of innovation based around optimizing the flow of carbon in living
systems. Yield10 is leveraging its technology platforms and
unique knowledge base to design precise alterations to gene
activity and the flow of carbon in plants to produce higher yields
with lower inputs of land, water or fertilizer. Yield10 is
advancing several yield traits it has developed in crops such as
Camelina, canola, soybean and rice. Yield10 is headquartered in
Woburn, MA and has an Oilseeds center of excellence in Saskatoon,
Canada.
For more information about the company, please visit
www.yield10bio.com.
(YTEN-G)
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical statements, including,
without limitation, expectations regarding the development of C3007
and C3010 as traits deployed to boost oil content in oilseed crops
and progress of Yield10 Bioscience, Inc., constitute
forward-looking statements. Such forward-looking statements are
subject to a number of risks and uncertainties that could cause
actual results to differ materially from those anticipated,
including the risks and uncertainties detailed in Yield10
Bioscience’s filings with the Securities and Exchange Commission.
Yield10 Bioscience assumes no obligation to update any
forward-looking information contained in this press release or with
respect to the announcements described herein.
Contact:
Lynne H. Brum, 617-682-4693,
LBrum@yield10bio.com
Investor Relations Contact:Amato and Partners,
LLCadmin@amatoandpartners.com
Media Inquiries: Eric FischgrundFischTank Marketing and
PReric@fischtankpr.com
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024